BioCentury | Dec 10, 2020
Finance
Dec. 9 Quick Takes: Nuance leads bolus of venture rounds for China’s innovators; plus launches for Hillhouse’s Overland, OSI’s PepGen and Atlas’ Vigil and more
...TARGETSTREM2 - Triggering receptor expressed on myeloid cells 2
BC Staff
Nuance Biotech
Hillhouse Capital
Pear Therapeutics
Atlas Venture
Mirum Pharmaceuticals
Genoimmune Therapeutics
OBiO Technology (Shanghai) Co. Ltd.
Beijing...
